ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,868.55
-0.22%
Dow Jones
42,392.27
-0.36%
US Dollar vs MXN
20.60855
-1.10%
Brent Oil
75.855
2.71%
Bitcoin
96,851.31
2.61%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Cadrenal Therapeutics Inc (CVKD)

  7. Cadrenal Therapeutics Inc (CVKD) Noticias

CVKD

Cadrenal Therapeutics (CVKD)

Cadrenal Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CVKD
FechaHoraFuenteTítuloSímboloCompañía
31/12/202407:00Business WireCadrenal Therapeutics Provides 2024 Year-End Company Update, Reinforcing Clinical Development Plan for Tecarfarin in LVAD and Other Rare Cardiovascular IndicationsNASDAQ:CVKDCadrenal Therapeutics Inc
23/12/202415:44Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CVKDCadrenal Therapeutics Inc
20/12/202416:28Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CVKDCadrenal Therapeutics Inc
18/12/202408:00Business WireCadrenal Therapeutics Gears Up for the 43rd Annual J.P. Morgan Healthcare Conference Week with Event Participation and Investor/Partner MeetingsNASDAQ:CVKDCadrenal Therapeutics Inc
25/11/202415:53Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CVKDCadrenal Therapeutics Inc
24/11/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CVKDCadrenal Therapeutics Inc
19/11/202408:00PR Newswire (US)Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech OutlookNASDAQ:CVKDCadrenal Therapeutics Inc
14/11/202415:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CVKDCadrenal Therapeutics Inc
14/11/202408:00Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:CVKDCadrenal Therapeutics Inc
12/11/202408:00PR Newswire (US)CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESSNASDAQ:CVKDCadrenal Therapeutics Inc
07/11/202415:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CVKDCadrenal Therapeutics Inc
07/11/202408:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CVKDCadrenal Therapeutics Inc
07/11/202408:00PR Newswire (US)CADRENAL THERAPEUTICS PROVIDES THIRD-QUARTER CORPORATE UPDATENASDAQ:CVKDCadrenal Therapeutics Inc
01/11/202419:00PR Newswire (US)Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross ProceedsNASDAQ:CVKDCadrenal Therapeutics Inc
24/10/202408:00PR Newswire (US)Cadrenal Therapeutics Raises $5.1 Million via At-The-Market FacilityNASDAQ:CVKDCadrenal Therapeutics Inc
23/10/202408:00PR Newswire (US)CADRENAL THERAPEUTICS JOINS CORPORATE COUNCIL OF ANTICOAGULATION FORUMNASDAQ:CVKDCadrenal Therapeutics Inc
04/10/202415:15Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CVKDCadrenal Therapeutics Inc
23/09/202415:15PR Newswire (US)Cadrenal Therapeutics to Participate in Lytham Partners Fall 2024 Investor ConferenceNASDAQ:CVKDCadrenal Therapeutics Inc
22/08/202408:00PR Newswire (US)Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD PatientsNASDAQ:CVKDCadrenal Therapeutics Inc
20/08/202408:00PR Newswire (US)Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD PatientsNASDAQ:CVKDCadrenal Therapeutics Inc
14/08/202408:00PR Newswire (US)Cadrenal Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:CVKDCadrenal Therapeutics Inc
07/08/202415:05PR Newswire (US)Cadrenal Therapeutics Provides Second Quarter 2024 Corporate UpdateNASDAQ:CVKDCadrenal Therapeutics Inc
06/08/202408:00PR Newswire (US)Cadrenal Therapeutics and Abbott Initiate Collaborative Effort to Advance Novel Anticoagulant Tecarfarin for Patients with LVADsNASDAQ:CVKDCadrenal Therapeutics Inc
12/06/202415:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CVKDCadrenal Therapeutics Inc
11/06/202416:27Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:CVKDCadrenal Therapeutics Inc
11/06/202416:25Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CVKDCadrenal Therapeutics Inc
03/06/202408:00PR Newswire (US)Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD PatientsNASDAQ:CVKDCadrenal Therapeutics Inc
29/05/202416:27Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CVKDCadrenal Therapeutics Inc
23/05/202408:00PR Newswire (US)Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024NASDAQ:CVKDCadrenal Therapeutics Inc
09/05/202408:00PR Newswire (US)Cadrenal Therapeutics Provides First Quarter 2024 Corporate UpdateNASDAQ:CVKDCadrenal Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CVKD

Su Consulta Reciente

COIN
SOLUSD
Solana
USOTC
BNPQY
BNP Paribas (QX)
CCOM
OILBRENT
Brent Oil
FX
USDMXN
US Dollar vs MXN
NYSE
VZ
Verizon Communications
USI
USTECH100
US Tech 100
USOTC
ADDYY
Adidas (QX)
COIN
DOGEUSD
Dogecoin
NYSE
MRK
Merck
NASDAQ
MSFT
Microsoft
COIN
ADAUSD
Cardano
AMEX
XLE
Energy Select Sector SPDR
COIN
ETHUSD
Ethereum
AMEX
XLF
Financial Select Sector
NASDAQ
TSLA
Tesla
AMEX
XLV
Health Care Select Sector
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados